Call points Dermatology and Key Oncology AccountsDisease State- Non Melanoma Skin Cancers and Lung Cancer

Drive strategic business collaboration opportunities with the major cancer centers within territory with GUARDANT 360 liquid biopsyStructure detailed strategic plans for gaining and retaining new and existing clients with GUARDANT 360 liquid biopsyMaximize client-bill contracting opportunities.Implement laboratory services agreements (LSA’s) with bill account institutions.Identify and develop partnering opportunities between prospective oncology clients.Promote and drive compliance with new web-based molecular information tools for all clients.Continually analyze competitive landscape and environment within assigned accounts to determine trends.Monitor performance of sales to ensure objectives are met.

Responsible for the promotion of BMS Oncology franchise of products to oncologists and hematologists. OPDIVO (Infusion), YERVOY (Infusion), EMPLICITI (Infusion) and SPRYCEL (Oral) to key Oncologists and Hematologists in the community setting. Also included providing educational workshops to Infusion, Nursing, Pharmacy and Key Financial Customers.Tumors represented and successful launches include: 1.Head and Neck Cancer, 2.Non-Small Cell Lung Cancer, 3.Small Cell Lung Cancer, 4.Renal Cell Carcinoma, 5.Urothelial Carcinoma, 6.Metastatic Melanoma, 7.Classical Hodgkin’s Lymphoma, 8.Colorectal Cancer, 9.Hepatocellular Carcinoma, 10.Multiple Myeloma and 11.Chronic Myelogenous Leukemia.Active in the Cancer Community by participating in Regional and Local Cancer Walks, Cancer Society Meetings, Fundraising Events and executing Patient Education programs in the community.• Q1 2018: Currently leading the Nation, Region and District in YTD Sales and Growth for PDL1 Share of 53.8% and Claims Growth by 16%.• Q1 2018: Currently leading the Nation, Region and District with Opdivo New Patient Starts for Opdivo at 65%.• Q4 2017: Opdivo 114.48% and Sprycel- 118.94%. Percentage IC Target Payout 117.87% for Q4 2017.• December 2017: National Winner for Maintaing 2L Lung Leadership Contest Competition.• December 2017: National Winner for Maintiaing 2L Lung Leadership Contest additional Kicker Competition.• 2016: Fort Worth Territory National Winners Circle Winner.• Appointed the Be Better member for the Region- partners with National Sales Leadership Society, Culture and Energy Committee and the National advocacy team on various regional and national initiatives for sales force and community.• Appointed District Sprycel Product Team Lead.• Appointed by sales leadership to be a member of the National Sales Based Intervention Team for Sprycel.

Repsonsible for promotion and launch of the Mutilpe Sclerosis Neurology franchise of products to institutional accounts and community accounts.TYSABRI (Infusion), PLEGRIDY (Injectable), TECFIDERA (Oral) and AVONEX (Injectable) to key Neurologists in the Multiple Sclerosis community; including Teaching Institutes (UTSW), Hospitals, Infusion Centers and Specialized Centers for Multiple Sclerosis. Work closely with internal and cross functional peers, included Market Access and Reimbursement and Medical Affairs to ensure that the Biogen suite of services is made available as needed. Active in the Multiple Scleorisis Community by participating in MS Walks, MS Society Meetings, fundraising events and executing Patient Education programs in the community.• #1 territory in the Region for 2015 sales for Biogen Franchise of products• Editor of the Divisional Business Managers Newsletter.• Q1 2016: 100% Plegridy and 103% for Tecfidera.• Q4 2015: 100% to goal for Plegridy, 134% to goal for Tysabri.• Q3 2015: 150% to goal for Plegridy, 205% to goal for Tysabri and 105% to goal for Tecfidera.• #1 territory in the region for Q2 and Q4 2014/5 for all products.• Q3 2014: 109% to goal for Tecfidera.• Q2 2014 : 111% to goal for Plegridy launch and 105% to goal for Tecfidera.• Performance Ratings- Consistently Exceeds Expectations.

Responsible for delivering medical education programs and clinical support to medical professionals, Met and exceeded sales goals by executing on Plan of Action marketing messages, including delivering branded sales messages, executing planned programs and providing clinical and economic benefits of offered products (EPOGEN; IV/ injectable, ARANESP; IV/injectable AND SENSIPAR; oral)• Responsible for servicing accounts to ensure product access, resolve reimbursement issues and maintain product contracts• Developed Sensipar Launch Model subsequently used by nation's sales representatives• Marketed various projects to improve persistency amongst patients in different disease state education and reimbursement challenges• Developed Training Module for ongoing training for sales representatives• 2007 and 2010: Chairman’s Circle Winner for, ranked #5 and #7 in nation. • 2006, 2007, 2010, and 2011: National Team Excellence Winner.• 2010: District Team Winner “Victory to Victoria”.• 2010: National Spirit of Amgen Winner- voted by peers.• 2008, 2009 and 2010: Top Gun Winner and Lunker Award Winner. • Interim District Sales Manager Position for the Atlanta District 2009.• Promoted to Executive Representative in 2008. (15% of nation's representatives only)• Performance Ratings - Consistently Exceeds Expectations and Top Performer.• District Sales Trainer for Minneapolis and Atlanta District for 2005, 2006, 2008, 2010 and 2011. • National Guest Trainer for New Hires at Corporate Headquarters Thousand Oaks, CA. • National Winner of Sensipar National Best Practice 2006.• 2005: National Winner of National Driving Outcomes Contest and National Decreasing Sub 10. • National Winner of Representative of the Year 2005.• Developed Sensipar Launch Model subsequently used by nation's sales representatives.• Developed National Training Module for ongoing training for sales representatives.

Responsible for promotion and sales of Eli Lilly’s osteoporosis portfolio:FORTEO (Injectable) and EVISTA (oral) to Endocrinologists and Rheumatologists.• Sucessfully implemented Launch Battle Plan for FORTEO, which was used nationally, this helped drive early adoption and uptake by key targeted physicians.• Worked closely with entire office to eduate and conduct workshops on injection process and support network.

Responsible for promotion and sales of pharmaceuticals products (PRILOSEC, TOPROL XL AND ATACAND) in both primary care and specialized settings.• 2000: #1 Sales Representative in the Nation for Prilosec Sales- 136% to goal.• Leader for the Peer-to-Peer Programs for 1999 and 2000.- completed of 26 programs in year 1999.• Team lead for territory, assisted in many new-hire training sessions